Glycosphingolipid changes induced by advanced glycation end-products

被引:8
作者
Natalizio, A [1 ]
Ruggiero, D [1 ]
Lecomte, M [1 ]
Lagarde, M [1 ]
Wiernsperger, N [1 ]
机构
[1] Inst Natl Sci Appl Lyon, LIPHA, INSERM, U352,Diabet Microangiopathy Unit, F-69621 Villeurbanne, France
关键词
diabetic retinopathy; glycosphingolipids; advanced glycation end products; endothelial cells; pericytes; gangliosides;
D O I
10.1006/bbrc.2001.4295
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effects of advanced glycation end-products (AGEs) on retinal microvascular cell glycosphingolipids were investigated as a potential pathogenic mechanism of diabetic retinopathy. The results obtained showed that, in microvascular retinal endothelial cells and pericytes, AGEs increased the amount of all glycosphingolipids studied (from 25 to 115% depending on the glycosphingolipid species), except for a specific ganglioside, GD3, which decreased by 35% only in pericytes. Glycosphingolipid profiles and GM3 fatty acid analysis did not show any qualitative differences after incubation with AGEs, suggesting that AGEs only induced quantitative changes in cell glycosphingolipids. These results show a new metabolic effect of AGEs, which could be involved in the microvascular alterations observed in diabetic retinopathy. (C) 2001 Academic Press.
引用
收藏
页码:78 / 83
页数:6
相关论文
共 31 条
[11]   GANGLIOSIDES PROTECT FROM TNF-ALPHA-INDUCED APOPTOSIS [J].
KOIKE, T ;
FEHSEL, K ;
ZIELASEK, J ;
KOLB, H ;
BURKART, V .
IMMUNOLOGY LETTERS, 1993, 35 (03) :207-212
[12]   Biosynthesis and functions of gangliosides: recent advances [J].
Lloyd, KO ;
Furukawa, K .
GLYCOCONJUGATE JOURNAL, 1998, 15 (07) :627-636
[13]   GLUCOSE TOXICITY IN THE VASCULAR COMPLICATIONS OF DIABETES - THE CELLULAR PERSPECTIVE [J].
LORENZI, M .
DIABETES-METABOLISM REVIEWS, 1992, 8 (02) :85-103
[14]   Modulation of EGF receptor activity by changes in the GM3 content in a human epidermoid carcinoma cell line, A431 [J].
Meuillet, EJ ;
Mania-Farnell, B ;
George, D ;
Inokuchi, J ;
Bremer, EG .
EXPERIMENTAL CELL RESEARCH, 2000, 256 (01) :74-82
[15]   Modification of enzymatic antioxidants in retinal microvascular cells by glucose or advanced glycation end products [J].
Paget, C ;
Lecomte, M ;
Ruggiero, D ;
Wiernsperger, N ;
Lagarde, M .
FREE RADICAL BIOLOGY AND MEDICINE, 1998, 25 (01) :121-129
[16]   GANGLIOSIDE G(M3) INHIBITS THE PROLIFERATION OF CULTURED KERATINOCYTES [J].
PALLER, AS ;
ARNSMEIER, SL ;
ALVAREZFRANCO, M ;
BREMER, EG .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 100 (06) :841-845
[17]  
Paques M, 1997, DIABETES METAB, V23, P125
[18]   Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro [J].
Podestà, F ;
Romeo, G ;
Liu, WH ;
Krajewski, S ;
Reed, JC ;
Gerhardinger, C ;
Lorenzi, M .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (03) :1025-1032
[19]   In vitro and in vivo alterations of enzymatic glycosylation in diabetes [J].
Rellier, N ;
Ruggiero-Lopez, D ;
Lecomte, M ;
Lagarde, M ;
Wiernsperger, N .
LIFE SCIENCES, 1999, 64 (17) :1571-1583
[20]  
Ruggiero D, 1997, DIABETES METAB, V23, P30